跳至主要内容
临床试验/NCT06995703
NCT06995703已完成不适用

Increasing Screening for Cancer Using EHR-Nudges, A Replication Trial

Abramson Cancer Center at Penn Medicine1 个研究点 分布在 1 个国家目标入组 8,490 人开始时间: 2025年6月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
8,490
试验地点
1
主要终点
Proportion of patients who complete a screening mammogram within 3 months after the visit

研究概览

简要总结

In this study, personalized nudges to clinicians and patients will be evaluated to help increase breast cancer screening rates in accordance with USPSTF guidelines among women with a primary care visit. In partnership with Penn Medicine (Penn) and Case Western Reserve University-University Hospitals (UH), two complementary, concurrent 6-month, cluster randomized, pragmatic trials were conducted from December 2023 to October 2024. This trial will now replicate those interventions at Lancaster General Health (LGH), incorporating learnings from the primary trials while also adapting to align with existing health system protocols and policies. The patient nudge interventions include pre- and post-visit text message reminders to encourage the patient to schedule their mammogram, and the clinician nudge intervention includes a Smart Data Element message in the electronic health record (EHR) reminding the care team that the patient is overdue and that patients are more likely to complete their screening if recommended and ordered by their clinician.

详细描述

Cancer is a leading cause of mortality in the United States. While strong USPSTF guideline recommendations support appropriate screening for early detection and to avoid preventable deaths, breast cancer screening is often underutilized. Increasing breast cancer screening rates is challenging, in part, because it requires complementary decisions from clinicians (e.g., recommend and counsel patients about screening) and patients (e.g., to internalize risks and choose to complete screening). Presently, the lack of interventions directly targeting both clinicians' and patients' decision-making may underscore the relatively stagnant screening rates in the United States. There is a significant need to develop and scale low-cost interventions that increase breast cancer screening while simultaneously addressing the needs of high-risk patients and reducing disparities. Building upon prior work, the investigators propose to develop and test EHR-based clinician and patient nudges at a replication site (Lancaster General Health) to help increase screening mammography rates. The analyses will compare the effectiveness of clinician and patient nudges in the overall patient population and separately among high-risk patients to inform what methods are most effective for each of these populations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Health Services Research
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 74 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •All patients must meet the following criteria to be eligible:
  • •Women between 40 and 74 years of age
  • •A scheduled new or return (non-urgent/sick) primary care visit at one of the study practices at Lancaster General Health
  • •Are overdue and eligible for a mammogram per Epic Health Maintenance
  • •Does not have a future scheduled mammogram appointment
  • •Patients meeting at least one of the following criteria will be considered high risk for screening non-completion:
  • •Medicare Insurance
  • •Medicaid Insurance
  • •No EHR patient portal account
  • •Zero log-ins to EHR patient portal in the previous year

排除标准

  • •Patients will be excluded from the study if they:
  • •Have a history of bilateral mastectomy, breast cancer, or metastatic cancer
  • •Have a mammogram exclusion modifier in Health Maintenance
  • •Have no phone number (home or mobile) listed in their chart

研究组 & 干预措施

Pre-Visit Text Message/Smart Data Element Only

Experimental

Patients randomized to this arm will receive the pre-visit text message and Smart Data Element nudges.

干预措施: Smart Data Element (SDE) (Behavioral)

Pre-Visit Text Message/Smart Data Element + Post-Visit Text Message

Experimental

Patients randomized to this arm will be eligible to receive both the pre- and post-visit text messages and the Smart Data Element nudges.

干预措施: Pre-Visit Patient Text Message (Behavioral)

Standard of Care

No Intervention

Patients randomized to the standard of care arm will receive no nudge interventions.

Pre-Visit Text Message/Smart Data Element Only

Experimental

Patients randomized to this arm will receive the pre-visit text message and Smart Data Element nudges.

干预措施: Pre-Visit Patient Text Message (Behavioral)

Pre-Visit Text Message/Smart Data Element + Post-Visit Text Message

Experimental

Patients randomized to this arm will be eligible to receive both the pre- and post-visit text messages and the Smart Data Element nudges.

干预措施: Post-Visit Patient Text Messages (Behavioral)

Post-Visit Text Message Only

Experimental

Patients randomized to this arm will be eligible to receive the post-visit text message nudges.

干预措施: Post-Visit Patient Text Messages (Behavioral)

Pre-Visit Text Message/Smart Data Element + Post-Visit Text Message

Experimental

Patients randomized to this arm will be eligible to receive both the pre- and post-visit text messages and the Smart Data Element nudges.

干预措施: Smart Data Element (SDE) (Behavioral)

结局指标

主要结局

Proportion of patients who complete a screening mammogram within 3 months after the visit

时间窗: 3 months

The primary outcome is screening mammogram completion within 3 months after the first eligible primary care visit.

次要结局

  • Proportion of patients who complete a screening mammogram within 6 months after the visit(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amol Navathe

Professor of Health Policy and Medicine

Abramson Cancer Center at Penn Medicine

研究点 (1)

Loading locations...

相似试验